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Multimorbidity and functional decline in
community-dwelling adults: a systematic
review
Aine Ryan1,3*, Emma Wallace1, Paul O’Hara2 and Susan M. Smith1
Abstract
Background: Multimorbidity affects up to one quarter of primary care populations. It is associated with reduced
quality of life, an increased risk of mental health difficulties and increased healthcare utilisation. Functional decline is
defined as developing difficulties with activities of daily living and is independently associated with poorer health
outcomes. The aim of this systematic review was to examine the association between multimorbidity and functional
decline and to what extent multimorbidity predicts future functional decline.
Methods: A systematic literature search (1990-2014) and narrative analysis was conducted. Inclusion criteria: Population;
Community-dwelling adults (≥18 years), Risk; Multimorbidity defined as the presence of ≥2 chronic medical conditions
in an individual, Primary outcome; Physical functional decline measured using a validated instrument, Study design;
cross-sectional or cohort studies. The following databases were included: PubMed, EMBASE, CINAHL, the Cochrane
Library and the International Research Community on Multimorbidity (IRCMo) publication list. Methodological quality
assessment of included studies was conducted with a suitable risk of bias tool.
Results: A total of 37 studies were eligible for inclusion (28 cross-sectional studies and 9 cohort studies). The majority
of cross-sectional studies (n = 24/28) demonstrated a consistent association between multimorbidity and functional
decline. Twelve of these studies reported that increasing numbers of chronic condition counts were associated with
worsening functional decline. Nine cohort studies included 14,133 study participants with follow-up periods ranging
from one to six years. The majority (n = 5) found that multimorbidity predicted functional decline. Of the five studies
that reported the impact of increasing numbers of conditions, all reported greater functional decline with increasing
numbers of conditions. One study examined disease severity and found that this also predicted greater functional
decline. Overall, cohort studies were of good methodological quality but were mixed in terms of participants,
multimorbidity definitions, follow-up duration, and outcome measures.
Conclusions: The available evidence indicates that multimorbidity predicts future functional decline, with greater
decline in patients with higher numbers of conditions and greater disease severity. This review highlights the
importance of considering physical functioning when designing interventions and systems of care for patients
with multimorbidity, particularly for patients with higher numbers of conditions and greater disease severity.
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Background
Multimorbidity is commonly defined as the co-occurrence
of two or more chronic medical conditions within an indi-
vidual [1]. Average life expectancy is rising and so too are
the numbers of patients living with multiple chronic med-
ical conditions [2, 3]. One of the main challenges facing
both healthcare providers and governments globally is to
provide healthcare for the growing numbers of patients
living with multiple co-existing diseases [4]. The preva-
lence of multimorbidity depends on the definition used
and the population studied and has been reported from
17–98 % [1, 10–12]. While linked to both deprivation and
ageing, this phenomenon is not exclusive to the elderly. In
an Australian study 15 % of the 40–59 age group suffered
with multiple co-existing medical conditions. A Scottish
primary care study demonstrated that the prevalence of
multimorbidity increased substantially with age and was
present in most of the cohort aged 65 years and older
(65–84 years: 64.9 % with multimorbidity). The study also
reported that 30.4 % of 45–64 year olds presented with
multimorbidity and given the higher numbers of people in
this age range, in absolute terms there are more middle
aged people with multimorbidity despite the perception
that is predominantly an issue for older patients [13].
Multimorbidity is the norm in clinical practice and has
been shown to be associated with increased healthcare
utilisation, increased emergency hospital admissions
and decreased quality of life [14, 15]. It has also been
associated with an increased decline in function [16].
Functional decline is defined as a deterioration in self-
care skills, where functional autonomy is diminished and
disability is increased [5, 6]. A systematic review of 14
cohort studies examining outcomes in older patients ad-
mitted to hospital found that functional status predicts
length of hospital stay, readmission rates, patient dis-
charge destination and also mortality [7]. In a Japanese
longitudinal study of patients over 65 years patients with
low Activities of Daily Living (ADL) scores, mortality rate
was twice as high over a 5 year follow up compared to pa-
tients with higher scores [8]. Functional decline can also
lead to increased rates of depression and decreased life
satisfaction [6, 9]. Conversely engaging in physical activity
is inversely associated with health care utilisation and is
associated with increased life satisfaction [6, 9, 17, 18].
It is important for healthcare providers to have a
greater understanding of the association between multi-
morbidity and functional decline considering its impact
on patient outcomes. A Cochrane review of interven-
tions to improve outcomes in patients with multimor-
bidity in primary care suggested that interventions
focusing on functional difficulties experienced by pa-
tients with multimorbidity may improve outcomes [19].
A previous systematic review completed in 2004 ex-
amined the relationship between multimorbidity and
quality of life in primary care and reported that mul-
timorbidity is associated with reduced quality of life
[20]. However, to date there has been no systematic
review of the literature examining the relationship be-
tween physical functioning and multimorbidity in com-
munity dwelling adults.
The aim of this systematic review was to examine
the association between multimorbidity and functional
difficulties and whether and to what extent multimor-
bidity predicts future functional decline.
Methods
The PRISMA-P Guidelines for reporting systematic re-
views were utilised in the conduct of this study [21].
The protocol for this study was published on an inter-
national prospective register for systematic reviews
(PROSPERO): http://www.crd.york.ac.uk/PROSPERO/
display_record.asp?ID=CRD42012003502.
Data sources
A systematic literature search was carried out using the
following search engines: PubMed, EBSCO, EMBASE,
CINAHL and the Cochrane library. References from re-
trieved articles were also searched by hand for relevant
articles. The search was carried out from January 1990
to November 2014 and was limited to publications in
the English language. Similar systematic reviews have used
1990 as a cut-off date for searches as multimorbidity was
a relatively new concept up to that date and does not ap-
pear in the literature before this time [16, 19]. Primary
healthcare, family practice and family physicians were
included as Medical Subject Heading (MeSH) terms.
As multimorbidity does not have a MeSH term is was
searched for as a keyword and comorbidity was used
as a MeSH term.
Two researchers performed the initial screening of
titles and abstracts (POH, EW) and irrelevant studies
were eliminated. Studies considered eligible for inclusion
were read fully in duplicate and their suitability for in-
clusion to the study was independently determined by
two researchers (AR, EW). Any ambiguous findings were
discussed with a third researcher (SS) and a consensus
reached. Additional information around eligibility was
sourced from authors where necessary.
Inclusion criteria
We included retrospective and prospective cohort studies
and cross-sectional study designs. Participants included
adults (>18 years) with multimorbidity defined as the
presence of two or more chronic medical conditions in an
individual [1]. The study setting was primary care or the
community. Primary care was defined as: integrated, easy
to access health care services by clinicians who are
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accountable for addressing a large majority of personal
health care needs, developing a sustained and continuous
relationship with patients, and practicing in the context of
family and community [22]. The primary outcome was
functional status measured using a validated measure of
function e.g. SF-36. Studies carried out in long term care/
residential settings and in-patient settings were excluded.
Studies that examined physical function in an index con-
dition and related co-morbidities were also excluded. The
current concept of multimorbidity is that no condition is
privileged over any other. Studies which investigate index
conditions and their co-morbidities also have a different
management focus targeting a single disease. This is dis-
cussed in a Cochrane review which investigates interven-
tions for patients with multimorbidity [19].
Assessment of risk of bias
Included studies were assessed for methodological qual-
ity using the Cochrane Tool for the Assessment of Bias
in Cohort Studies [23] (Additional file 1: Appendix A).
This checklist was modified for assessment of the included
cross-sectional studies (Additional file 2: Appendix B).
Statistical analysis
Due to heterogeneity meta-analysis was not possible
and a narrative synthesis was conducted. Each article
was assessed under the following headings; publication
year and country, population and setting, definition and
prevalence of multimorbidity, functional decline outcome
measure, findings and follow up period (cohort studies).
Results
Of 5532 articles screened, 89 were assessed in full text
and evaluated according to the study’s inclusion and ex-
clusion criteria. A total of 37 studies were eligible for in-
clusion: 28 cross-sectional studies [24–52] and 9 cohort
studies [53–60]. Figure 1 illustrates the search strategy.
Reasons for exclusion of studies are presented in the
flow diagram and references provided as an appendix
(Additional file 3: Appendix C). Tables 1 and 2 describe
the study designs, definitions and outcomes reported in
the 37 included studies.
Cross sectional studies
The 28 cross-sectional studies included 1,357,498 partici-
pants in total. Overall, 22 of the 28 studies included par-
ticipants aged over 50 years with 11 of these including
participants aged 60 years or older. Sample sizes varied
from 186 [33] to 830,537 [47]. The studies were carried
out in twelve different countries, the majority in Europe
(n = 13) and North America (n = 11). A total of 22 studies
measured multimorbidity using the definition of two or
more conditions with three studies using three or more
conditions. Two studies used weighted indices such as the
Charlson Co-morbidity Index to measure the degree of
multimorbidity. Ascertainment of conditions varied be-
tween self-report, physician report, chart review and use
of software, with the majority (n = 17) using self-report to
identify conditions. To note, five of the 28 studies did not
include mental health conditions [36–39, 50]. There was
significant variation in the prevalence of multimorbidity in
included studies ranging from 13 % [50] to 90 % [31].
Ten different validated outcome measures were used
to measure functional decline in the included 28 studies.
Approximately half (46.4 %) used the SF-36 /SF-12,
followed by 25 % administering the EQ-5D. The majority
of cross-sectional studies demonstrated a consistent as-
sociation between multimorbidity and functional decline
(n = 24/28). Twelve of these studies reported that higher
condition counts were associated with increased func-
tional decline. In contrast two studies concluded that
there was no significant association between the num-
ber of conditions and physical functioning [25, 49]. Two
studies reported that higher morbidity severity was as-
sociated with poorer physical health [34, 42].
Cohort studies
A total of nine cohort studies included 14,133 study par-
ticipants with follow-up periods ranging from one to six
years [52–60]. Six of these nine studies included partici-
pants 65 years or older with sample sizes varying be-
tween 492 [60] and 4672 [59]. Four studies were
conducted in Europe, four in North America and one
study in Australia. The majority defined multimorbidity
as ≥2 chronic conditions but most restricted condition
inclusion using pre-defined lists ranging from five to 96
conditions. Similar to the cross-sectional studies, self-
report was the most prevalent method of ascertaining
conditions (n = 5), followed by identification through
medical record review (n = 4). There was similar vari-
ation in prevalence rates of multimorbidity in the cohort
populations, ranging from 25.3 to 93.1 %. Five different
validated outcome measures were used with just over half
of the cohort studies (n = 5) using the SF-36 or SF-12 as
their measure of functional decline.
Seven of the nine cohort studies reported that base-
line multimorbidity predicted future functional decline
[53–56, 58–60]. Five studies out of nine established that
any degree of multimorbidity was predictive of func-
tional decline [53, 55, 56, 59, 60]. Two of these studies
stipulated that specific numbers of chronic conditions
at baseline were predictive of future decline [54, 58].
The remaining two studies reported that higher num-
bers of conditions were needed to predict future decline
with Nikolova at al. [58] reporting significant functional
decline only for those with four or more conditions and
Bayliss et al. [17] reporting it for those with six or more
conditions. Two studies found no significant
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relationship between functional disability and multi-
morbidity over time [52, 57]. Abizanda et al [52] stated
that disability and frailty were not associated with multi-
morbidity over two years [52]. Kiely et al [57] reported
that additional conditions were associated with in-
creased impairment at baseline but that functional de-
cline over time did not differ between subjects with no
conditions and those with multimorbidity [57].
Five studies examined condition type, disease severity
and the impact of cognitive impairment on functional
decline. Bayliss et al. examined condition type and re-
ported that those with congestive heart failure, diabetes
and/or chronic respiratory disease were at greater risk of
functional decline over time compared to other condi-
tions [54]. Prior et al. also examined condition types and
reported that those with cardiovascular disease were
Fig. 1 Flow diagram of search
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Table 1 Included Cross-Sectional Studies
Author
Publication
Year
Country
Population and setting Definition and prevalence of
multimorbidity (MM)
Functional decline
outcome measure
Results
Agborsangaya 2012 Canada Population based
survey 4946 adults
≥ 18 years
Self-report chronic conditions
from list of 1619 % with
≥ 2 conditions
EQ–5D MM associated with a significant reduction in EQ5D
index score -0.12
Baker 2000 USA Primary care clinic194 adults,
48 % > 60 years
Self-report of > 1 diagnosis
according to ICPC categories
51 % > 1 condition
SF– 36 SF36 PCS scores decline with increasing numbers
conditions (p < 0.05 on one way MANOVA analysis)
Baker 2006 USA Community dwelling 247
African American adults,
mean age 69
Self-report of doctor-diagnosed
conditions used to create
condition count
Mean 2.9 conditions
AIMS2 (Arthritis Impact
Measurement Scale)
No significant association between number of conditions
and physical functioning on multivariate analysis
Bayliss M2012 USA Population based
survey 3877 adults63 %
≥ 45 years36 %
≥ 60 years
Self-report of conditions
from 26 condition checklist
Mean 2.4 conditions
Grouped into physical
condition MM, mental health
MM or both
SF–36 Reduction in PCS score v healthy group:Physical
MM : - 6.4Mental health MM: - 11Combined physical and
mental health MM: -15
Bayliss EA2012 USA Primary care, members of
HMO961 aged ≥ 65 years
Self-report of 3 or more
conditions from a list of
10 conditions
Mean 7.9 conditions
SF–36 Higher condition counts associated with significantly lower
PCS scores on multivariate analysis
Brettschneider 2013 Germany Primary Care – GP databases
3189 patients 65–85 years
Co-existence of 3 or more
chronic conditions from
a list of 29
Measured by a weighted
counts score
Mean 7 conditions
EQ–5D Increased condition count and severity associated with significant
reductions in EQ5D-VAS on
multivariate analysis
Cesari 2006 Italy Population – cohort study
in mountain community
364 adults≥ 80 years
Physician report of≥ 3
conditions based on self-
report and chart review
136 patients with ≥ 3
conditions (37.4 %)
Short Physical
Performance Battery
(SPPB)
Four minute walking
speed scoreMDS-HC:
ADLs and IADLs
MM significantly associated with lower SPPB score, lower
walking speed scores and lower IADLs, but no difference
in ADLs
Chen 2011 USA Population based survey
(Behavioural Risk Factor
Surveillance System)
430,912 adults ≥18 years
Self-report from list of 8
conditions
>90 % participants had≥ 2
conditions
CDC HRQOL - 4
domains: general health,
mental distress, physical
distress and activity
limitations
Participants with≥ 3 conditions had highest risk of reporting
fair or poor health (AOR 8.7, 95 % CI 8.0 to 9.4)
Cheng 2003 USA Primary care clinics 316
consecutive clinic attenders
55 –64 years
80 % of patients in the study
had ≥ 2 conditions confirmed
on chart review
SF–36 Number of conditions significantly associated with decreases
in PCS scores in multivariate analysis
Formiga 2005 Spain Community based186
adults aged ≥ 90 years
Charlson Comorbidity index,
mean score 1.43
Higher comorbidity score significantly associated with worse
functional and cognitive capacity on multivariate analysis
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Table 1 Included Cross-Sectional Studies (Continued)
Barthel Index (ADLs)
Lawton and Brody Scale
(IADLS)
Fortin 2007 Canada Primary care 238 adults
attending primary care clinic
(randomly collected from a
larger study cohort)
Mean age 59.0 years
Chart confirmed≥ two
conditionsSeverity assessed
using CIRS score
Mean 5.3 (+/-2.8) diagnoses
SF–36 MM measured by simple count was associated with significantly
reduced PCS scores on multivariate analysis
Increases in MM severity (CIRS scores) associated with greater
decreases in PCS scores than simple counts alone
Goins 2010 USA Community based sample
505 adults≥ 55 years
Comorbidity scale –
self-report from list of
32 conditions
Combined with severity
assessment using score 0–3
Mean score 5.8
Short Physical
Performance Battery
(SPPB)
Hand grip test
Higher comorbidity scores significantly associated with poor
SPPB and hand grip scores in multivariate analysis
Griffith 2010 Canada Population based sample
8858 adults ≥ 65 years
Self-report of≥ 2 from list of
12 conditions72.0 % with≥ 2
conditions
Multi-dimensional
functional assessment
questionnaire (OARS)
Combination of foot problems, arthritis and heart problems
had most impact on functional disabilities on multivariate analysis
A significant association between 11 conditions and functional
disability.
Heyworth 2009 UK Primary care registered
patients 4836 adults
Mean age 47.9
Self-report from a list of 6
conditions, confirmed by
chart review24 % had≥ 2
conditions
EQ-5D Increasing numbers conditions significantly associated with
lower EQ5D scores on multivariate analysis
Hunger 2011 Germany Population based 4412
adults≥ 65 years
Self-report of≥ 2 conditions
from a list of 6 conditions
Prevalence of MM within
sample not reported
EQ-5D Combinations of conditions significantly associated with reduced
EQ5D index scores on multivariate analysis (examined in pairs and
compared to single condition alone)
Jayasinghe 2009 Australia Primary care 96 General
practices 7606 adults
≥ 18 years
Mean age 59.1
Software selected patients
with at least one of three
chronic conditions.
MM: two or more chronic
conditions. n = 1497
(19.7 %)
SF-12 Number of chronic conditions negatively associated with PCS-12
scores (physical component summary).
Joshi 2003 India Population based survey200
adults≥ 60 years
Self-report of conditions
(ICD-10 codes) confirmed by
chart review
83 % had
≥ 4 conditions
Standardised Rapid
Disability Rating Scale-2
Number of conditions significantly associated with increased
mean disability scores
Kadam 2007 UK Primary care registered
patients 9439 aged
≥ 50 years
1. Simple condition counts
using chart review for≥ 2
coded conditions81 %
had ≥ 2 conditions
2. Combinations of 185
selected conditions classified
by severity on 4 point scale
by GPs
SF-12 dichotomised into
poor and good function
Increasing number of conditions significantly associated with
poor physical function.
AOR 1.6 for 2 or 3 conditions
AOR 5 for ≥6 conditions
Increasing strength of association between MM
severity and poor function
Kadam 2009 UK SF-12
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Table 1 Included Cross-Sectional Studies (Continued)
Primary care 8791 English
aged≥ 50 years 7753 from
Netherlands aged≥ 18 years
Classified based on 78
conditions which were
classified on a 4 point severity
index by GPs
Higher morbidity severity was significantly associated with
poorer physical health on multivariate analysis
Keles 2007 Turkey Community based survey
4605 parents /grandparents
Mean age 53.2 (male) 51.6
(female)
Self-report of conditions from
a list of 11 conditions
46 % of participants >1
chronic condition
(n ~ 2118)
SF-12 As number of chronic conditions increased physical
functioning declined
Number of comorbidities an independent predictor of
physical functioning
Kim 2012 Korea Population based survey
1419 adults
≥65 years
Self-report of≥ 2 conditions
from list of 20 conditions
Mean 3.88 conditions
EQ-5D MM significantly associated with lowerEQ-5D index score in
multivariate analysis
Lawson 2013UK Population based survey
7054 aged≥ 20 years
Self-report of≥ 2 conditions
from list of 40 conditions
18 %≥ 2 conditions
SF-12
(no breakdown into
physical component
scores)
Number of conditions all significantly associated with reductions
in SF12 scores in multivariate analysis
Michelson 2001 Sweden Population based survey
3069 adults, Mean age 51
Self-report from list of 13
conditions
Categorised into groups - no
problems
(0 conditions); few problems
(1-2 conditions); some
problems (3-4 conditions) and
a lot (5-13 conditions) 28 %
had some or a lot of problems
EORTC QLQ-C30
(HRQOL, specific to
Cancer)
Multiple chronic health problems significantly associated with
reduced HRQOL adjusted for age
Mujica-Mota 2014 UK Population based survey
831,537 aged≥ 18 years
Self-report of≥ 2 conditions
from list of 12 conditions
23 %≥ 2 conditions
EQ-5D Number of conditions significantly associated with decrease in
EQ-5D scores in multivariate analysis
Noel 2007 USA Primary care enrolled patients
422 adults Mean age 57 years
≥2 ICD-9 coded conditions
from a list of 45 conditions
54 %≥ 2 conditions
SF-12 Multimorbidity group had significantly lower PCS score (34.8)
compared to single morbidity group (39.5)
Parker 2014 UK Population based survey 5849
adults≥ 65 years
Self-report of≥ 2 conditions
from list of 15 conditions,
verified by chart review
HADS score for depression
26 %≥ 2 conditions
EQ-5D Total number of conditions not associated with decreased
EQ-5D scores on multivariate analysis
Rijken 2005 Netherlands Primary care sample 1673
chronic disease patients
Coded conditions identified by
chart review from list of six
conditions13 %≥ 2 conditions
SF-36 Multimorbidity associated with significantly lower PCS scores
Wensing 2001 Netherlands Primary care attenders
4040 adults
(28 % ≥ 60 years)
Self-report of≥ 2 conditions
from a list of 25 conditions
16 %≥ 2 conditions
SF-36 Increasing number conditions associated with lower PCS
scores but effect disappeared when controlled for age
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Table 2 Included Cohort Studies
Author
Publication
Year
Country
Population and setting Definition and prevalence of multimorbidity
(MM)
Functional decline
outcome measure/s
Follow-up
periodLosses to
follow-up (%)
Results
Abizanda
2014 Spain
General population
(FRADEA Study)
842 adults aged >70 yrs
MM ≥2 chronic diseases in a specific
period of time.
14 pre-specified conditions selected for
prevalence and impact on
disability/mortality
Chronic diseases identified from medical
records and coded via ICD-10
580≥ 2 conditions (69.0 %)
Barthel index (disability)
Fried’s criteria (frailty)
2 years7.5 % loss to
follow-up
Disability and frailty was not
associated with MM over two years.
Aarts 2012
Netherlands
Primary care
(Maastricht Aging Study)
1184 adults aged 21–84 years
MM ≥2 chronic diseases co-occurring within
one person
Morbidities sourced from GP database including
all current and past health
problems by clinician96 included conditions
based on medical literature and
clinical experience35.5 % ≥ 2 chronic diseases
SF-36 3 and 6 years16.4 %
loss to follow-up
MM significantly associated with
poorer physical functioning at all
3 follow-up points (p < 0.001)
Significant steep decline in physical
function between 3 and 6 year follow up
in those with MM (p < 0.001)
Participants whose morbidity status changed
from baseline to 3 year follow up (either to
single or MM) associated with
significantly lower physical function (p < 0.001)
Bayliss 2004
USA
Primary care
(Medical Outcomes Study)
2708 adults, mean age
57.6 years
No definition of MM reported
Self-report of 7 pre-specified chronic conditions.
Condition presence also sourced from records
Conditions chosen as of high
prevalence in practice and in literature
686≥ 2 chronic diseases (25.3 %)
SF-36(PCS scores) 4 years41.9 % loss
to follow up
≥4 chronic diseases associated with significant
decline in physical function (p < 0.05) Reduction in
PCS by 6.5 used as criteria for clinically significant
<4 chronic diseases no association with physical
decline
Congestive Heart Failure, diabetes and/or respiratory
disease predictive of clinically significant decline in
PCS (p <0.05)
Byles 2005
Australia
Primary care
(Veteran’s Affairs Preventative
Care Trial)
1417 adults≥70 years
Co-existence of multiple diseases in the same
individual
Self-reported MM questionnaire consisting of
25 conditions
Severity measure incorporated and included mild
cognitive decline
1107 > 3 conditions (78.1 %)
SF-36 2 years7.2 % lost
to follow up
Quality of Life (QoL) decreases as number of
conditions increases
The presence of each condition associated with
significantly lower SF-36 scores (except heart bypass,
stroke and diabetes)
Data not shown
Drewes
2011
Netherlands
General population
(Leiden 85–plus study)
594 adults aged 85 years
MM ≥2 chronic diseases at age 85 years
Chart confirmed presence of 9 common
conditions pre-specified
234≥ 2 chronic diseases (39.4 %)
Groningen Activity
Restriction Scale
5 years53.9 % loss
to follow up
Participants with MM had an accelerated progression
of ADL (activities of daily living) disability over time
compared to those without MM (95 % CI 0.21 -0.63,
p < 0.001)MM demonstrated accelerated increase in
ADL disability in older people with optimal cognitive
function (95 % CI 0.39-0.95, p < 0.001) This was not
observed in participants with lower MMSE scores.
Kiely 1997
USA
Community based
(Sample first drawn 1982:
Massachusetts state-supported
home care programme)
1060 adults aged ≥65 years
No definition of MM reported
Self-report of 5 pre-specified medical conditions
MM numbers not reported
Functional Dependency
Index(FDI)
3 years22.5 % loss
to follow up
Each additional medical condition resulted in a
significant increase in the FDI score (p < 0.001)
Rate of decline did not differ by total number of
medical conditions
(p =0.67)
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Table 2 Included Cohort Studies (Continued)
Nikolova
2011
Canada
Community based
(Research Program on Integrated
Services for the Elderly)
1164 disabled adults ≥65 years
Disability status estimated
using the Functional Autonomy
Measurement System (SMAF)
Score ≥10 excluded
Comorbidity : number of chronic diseases
Self-report of comorbidities using 16 item
questionnaire
Diseases not specified but grouped into
four categories:
0-1 disease2-3 diseases4-5 diseases
≥6 diseases
1084≥ 2 diseases (93.1 %)
Functional status
measured using 7 item
IADL subscale of the
OAR and Katz ADL
index
3 yearsHigh rate of
attrition discussed
but loss to follow
up number NR
Comorbidity burden is a strong predictor
in developing IADL and ADL disability
6 diseases vs 0–1
diseaseOR (95 % CI)IADL 6.42 (1.52; 27.18)
ADL 16.73 (3.08; 91.06) 4 –5
diseases vs 0–1 diseaseOR(95 % CI)IADL 1.20
(0.52; 2.80)
ADL 0.89 (0.26; 2.98) 2–3 diseases vs 0 –1
diseaseOR(95 % CI) IADL 1.00 (0.46; 2.20)
ADL 1.44 (0.49; 4.15) ≥6 morbidities-6 times more
likely to develop ADL disability and 17 times more
likely to develop IADL disability
Prior
2011UK
Primary care
4672 adults aged ≥50 years
Comorbidity –number of chronic diseases
Record confirmed condition counts over
previous 2 yearsIn addition to number
of GP consultations for morbidity in 2 year period
Specific cardiovascular and musculoskeletal
conditions (n = 15) chosen as most prevalent in
developed countries
Stage of disease as proxy for severity
561≥ 1 CVD & MSK condition
MM in overall group not reported
SF-12 (PCS) 3 years46 % loss to
follow up
Cardiovascular cohort: higher comorbidity and
increasing severity in disease associated with
greater deterioration in PCS.
Significant deterioration shown for HTN
(p < 0.001) with PCS score deteriorating by -0.86
over three years
Musculoskeletal cohort: no association
Rigler 2002
USA
Community based
(Veteran’s Affairs Medical Centre)
492 adults aged ≥65 years
Comorbidity scores: based on sum of the
domains affected, and the sum of the domains
which patients reported affected function.
Self-report of 18 prevalent conditions from 8
organ domains via self-report335≥ 2 diagnoses
(68.1 %)
MOS-36Physical
Function IndexSelf-
report ADL and IADL
1 year7.2 % loss to
follow up
Increasing comorbidity significantly associated
with increased risk of future functional decline
(p <0.001)
OR 1.09: 2 conditions OR 2.41: ≥ 3 conditions
Presence of ADL and IADL problems at baseline
demonstrated to have a significant impact on
new ADL problems developing at one year
(p <0.001) OR 4.77: 1 IADL problem at baseline
OR 15.6: 1 ADL problem at baseline
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more likely to have deterioration in physical health com-
pared to those with musculoskeletal conditions [59]. Dis-
ease severity was also examined in this study and was
found to predict greater functional decline [59]. Two cross-
sectional studies examined six different conditions and their
combinations [38, 50]. Hunger et al. reported that stroke
and bronchitis in combination had the greatest negative im-
pact on function. Rijken et al. stated that combinations of
diabetes, cardiovascular disease and chronic respiratory dis-
ease lead to a higher risk of physical disability. Drewes et al.
examined the role of cognitive impairment in predicting
disability in patients with multimorbidity [56]. They found
that multimorbidity predicted an accelerated increase in
ADL disability in participants with optimal cognitive func-
tion at baseline, but not in participants with lower MMSE
scores at baseline. This may be explained by the fact that
those with poor cognitive function at baseline already had
higher levels of disability so had less change in function
over time.
One study analyzed the accrual of additional condi-
tions over time and the impact that this had on function
decline [53]. The authors reported that participants
whose morbidity status changed from baseline to three
year follow up (either to single or multimorbidity) had
significantly lower physical function at follow up.
Risk of bias in included studies
Overall, the methodological quality of the included studies
was good. The risk of bias assessment is presented in
Figs. 2a and b. The majority of cross-sectional studies used
valid and reliable outcome measures (n = 18) and most
studies accounted for possible confounders (n = 24). We
can also be reasonably confident that multimorbidity was
measured appropriately. All papers used valid outcome
Fig. 2 Methodological quality assessment of the included studies as per Cochrane Tool for risk of bias (Additional file 1: Appendix A and Additional file 2:
Appendix B). a Cross-sectional studies (n= 28), b Cohort studies (n= 9)
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measures however, blinding and details of assessors was
not reported in all. The majority of the cohort studies
reported adequate follow up over time (n = 6) along with
appropriate adjustment for confounding (n = 7). Overall,
the outcome measures used were suitable and participant
groups were well matched.
Discussion
Overall findings
This systematic review retrieved 37 relevant studies
(nine cohort studies and 28 cross-sectional). Overall the
majority of studies demonstrated an association between
multimorbidity and functional decline. In addition,
77.8 % (seven out of nine) of the included cohort studies
reported that multimorbidity predicts future functional
decline. This was more marked with increasing numbers
of conditions and was also linked to condition severity.
Two cohort studies reported no significant association
between functional disability and multimorbidity over
time [52, 57]. The conditions included in these studies
did not vary considerably from those seven studies
which did demonstrate significance (Additional file 4:
Appendix D). However, both studies included partici-
pants aged 70 years or older [52] and 65 years or older
[57]. Abizanda et al. reported that functional ability was
impaired at baseline in their participants [52]. It could
be argued that the detection of further functional decline
was limited due to the age group of participants.
This review adds to the growing evidence base exam-
ining the negative impact of multimorbidity on patient
outcomes. It highlights a potential cumulative effect in
that both multimorbidity and functional decline inde-
pendently predict poorer outcomes. This review examines
one direction of effect, i.e. that baseline multimorbidity pre-
dicts future functional decline but it is also possible that
poor physical functioning will lead to worsening of multi-
morbidity, a relationship that our study group plan to
examine in an ongoing prospective cohort study in Ireland
[61]. For instance, patients with poorer physical function
may be less able to engage in physical activity, which may
then worsen health through weight gain or other effects on
well-being. There is also considerable overlap with the con-
cept of frailty which is also receiving increasing attention in
the literature [62].
The findings of this review are consistent with existing
evidence linking multimorbidity and poorer health re-
lated quality of life [16]. It is also consistent with the
qualitative literature exploring the perspectives of pa-
tients with multimorbidity, which highlights problems
with daily functioning [63]. Some of the impact of multi-
morbidity on functional decline may relate to the emer-
ging concept of treatment burden [64] as those with
multiple conditions are more likely to be attending
multiple healthcare providers and undergoing complex
treatments.
Strengths and limitations of this review
We can be reasonably confident in the findings of this
review as overall, there was minimal risk of bias in the
included studies. However, variation in participants,
multimorbidity definitions, follow-up duration, and out-
come measures resulted in meta-analysis not being pos-
sible. The included studies also varied widely in the
number and age of participants. This will have intro-
duced some selection bias for participants. For example,
one study reported that 20 % of non-responders and
10 % of responders were less than 40 years [39]. There
was also disparity in the prevalence of multimorbidity
in the included studies and not all studies examined
the impact of numbers of conditions condition type
and possible combinations or condition severity. The
study settings varied which adds to generalizability
though all were conducted in high income countries so
results may not apply outside these settings. A further
potential limitation was only studies published in English
were included.
Implications of findings
This review highlights the need to carefully consider
functional decline in patients with multimorbidity. The
Cochrane review of community-based interventions to
improve outcomes for people with multimorbidity sug-
gested that such an approach could have a role to play
in improving outcomes [19]. Two studies included in
the updated Cochrane review had a strong focus on
physical functioning and investigated occupational ther-
apist and physiotherapist led interventions [65, 66]. Both
studies reported significant improvements in patient
outcomes including functional capacity with one demon-
strating a reduction in mortality over time [66] Future
research should focus on the development and testing of
interventions that incorporate a multidisciplinary ap-
proach that prioritizes physical function for this patient
group. This is particularly important for patients with
higher numbers of conditions and greater disease se-
verity. Such an approach was also advocated in a recent
clinical management review of multimorbidity, which
also suggested that, depending on patient priorities,
general practitioners should consider referral to allied
health professionals who can intervene to prevent
physical decline [67].
Given the complexities highlighted in this review
around participant selection and definitions of multi-
morbidity, future research should be mindful that such
variability in terminology exists and carefully consider
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these issues when developing and reporting interven-
tions [68].
Conclusion
Multimorbidity is recognised internationally as having
a serious impact on health outcomes. This systematic
review suggests that multimorbidity predicts future
functional decline, which in turn will worsen health
outcomes. Interventions are needed that effectively
protect physical function in patients with multimor-
bidity to prevent this inevitable cascade towards
poorer health outcomes.
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